PubMed

Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions.

Vuorela P, Ala-Mello S, Saloranta C, Penttinen M, Pöyhönen M, Huoponen K, Borozdin W, Bausch B, Botzenhart EM, Wilhelm C, Kääriäinen H, Kohlhase J.

Genet Med. 2007 Oct;9(10):690-4.PMID: 18073582 [PubMed - indexed for MEDLINE]Related articles

The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.

Ylönen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C; Botnia Research Group.

Eur J Clin Nutr. 2008 Dec;62(12):1432-9. Epub 2007 Aug 15.PMID: 17700648 [PubMed - indexed for MEDLINE]Related articles

Genetic prediction of future type 2 diabetes.

Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjögren M, Saloranta C, Tuomi T, Groop L; Botnia Study Group.

PLoS Med. 2005 Nov 1;2(12):e345.PMID: 17570749 [PubMed - indexed for MEDLINE]Related articlesFree article

[Diabetic with hallucination]

Saloranta C, Tuomi T.

Duodecim. 2005;121(21):2319-20. Finnish. No abstract available. PMID: 16457114 [PubMed - indexed for MEDLINE]Related articles

Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.

Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissén M, Isomaa B, Forsen B, Homström N, Saloranta C, Taskinen MR, Groop L, Tuomi T; Botnia study group.

Diabetes. 2005 Jan;54(1):166-74.PMID: 15616025 [PubMed - indexed for MEDLINE]Related articlesFree article

Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.

Tripathy D, Lindholm E, Isomaa B, Saloranta C, Tuomi T, Groop L.

Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1297-303. Epub 2003 Sep 3.PMID: 12954593 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations of dietary fiber with glucose metabolism in nondiabetic relatives of subjects with type 2 diabetes: the Botnia Dietary Study.

Ylönen K, Saloranta C, Kronberg-Kippilä C, Groop L, Aro A, Virtanen SM; Botnia Dietary Study.

Diabetes Care. 2003 Jul;26(7):1979-85.PMID: 12832299 [PubMed - indexed for MEDLINE]Related articlesFree article

Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study.

Ylönen K, Alfthan G, Groop L, Saloranta C, Aro A, Virtanen SM.

Am J Clin Nutr. 2003 Jun;77(6):1434-41.PMID: 12791620 [PubMed - indexed for MEDLINE]Related articlesFree article

Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.

Saloranta C, Guitard C, Pecher E, De Pablos-Velasco P, Lahti K, Brunel P, Groop L.

Diabetes Care. 2002 Dec;25(12):2141-6.PMID: 12453951 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.

Saloranta C, Hershon K, Ball M, Dickinson S, Holmes D.

J Clin Endocrinol Metab. 2002 Sep;87(9):4171-6.PMID: 12213867 [PubMed - indexed for MEDLINE]Related articlesFree article

Heritability of albumin excretion rate in families of patients with Type II diabetes.

Forsblom CM, Kanninen T, Lehtovirta M, Saloranta C, Groop LC.

Diabetologia. 1999 Nov;42(11):1359-66.PMID: 10550421 [PubMed - indexed for MEDLINE]Related articles

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC.

Diabetes. 1999 Jan;48(1):150-7.PMID: 9892237 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.

Forsblom CM, Sane T, Groop PH, Tötterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepäntalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L.

Diabetologia. 1998 Nov;41(11):1253-62.PMID: 9833930 [PubMed - indexed for MEDLINE]Related articles

Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.

Forsblom CM, Groop PH, Ekstrand A, Tötterman KJ, Sane T, Saloranta C, Groop L.

Diabetes Care. 1998 Nov;21(11):1932-8.PMID: 9802746 [PubMed - indexed for MEDLINE]Related articlesFree article

Interactions between glucose and FFA metabolism in man.

Saloranta C, Groop L.

Diabetes Metab Rev. 1996 Apr;12(1):15-36. Review. No abstract available. PMID: 8861499 [PubMed - indexed for MEDLINE]Related articles

The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation.

Ekstrand A, Schalin-Jäntti C, Löfman M, Parkkonen M, Widén E, Franssila-Kallunki A, Saloranta C, Koivisto V, Groop L.

Transplantation. 1996 Mar 27;61(6):889-93.PMID: 8623155 [PubMed - indexed for MEDLINE]Related articles

The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Taskinen MR.

Acta Diabetol. 1994 Apr;31(1):6-13.PMID: 8043900 [PubMed - indexed for MEDLINE]Related articles

Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.

Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Eriksson J, Taskinen MR.

Diabet Med. 1993 Dec;10(10):950-7.PMID: 8306591 [PubMed - indexed for MEDLINE]Related articles

Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.

Saloranta C, Taskinen MR, Widen E, Härkönen M, Melander A, Groop L.

Diabetes. 1993 Nov;42(11):1559-66.PMID: 8405695 [PubMed - indexed for MEDLINE]Related articles

Contribution of muscle and liver to glucose-fatty acid cycle in humans.

Saloranta C, Koivisto V, Widén E, Falholt K, DeFronzo RA, Härkönen M, Groop L.

Am J Physiol. 1993 Apr;264(4 Pt 1):E599-605.PMID: 8476039 [PubMed - indexed for MEDLINE]Related articles

Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus.

Groop LC, Kankuri M, Schalin-Jäntti C, Ekstrand A, Nikula-Ijäs P, Widén E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C, et al.

N Engl J Med. 1993 Jan 7;328(1):10-4. Erratum in: N Engl J Med 1993 Apr 15;328(15):1136. PMID: 8416266 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Widén E, Ekstrand A, Saloranta C, Franssila-Kallunki A, Eriksson J, Schalin-Jäntti C, Groop L.

Diabetologia. 1992 Dec;35(12):1140-5.PMID: 1478365 [PubMed - indexed for MEDLINE]Related articles

Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man.

Ekstrand A, Saloranta C, Ahonen J, Grönhagen-Riska C, Groop LC.

Metabolism. 1992 Jul;41(7):692-7.PMID: 1619986 [PubMed - indexed for MEDLINE]Related articles

Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.

Groop LC, Widén E, Ekstrand A, Saloranta C, Franssila-Kallunki A, Schalin-Jäntti C, Eriksson JG.

Diabetes Care. 1992 Jul;15(7):831-4.PMID: 1516500 [PubMed - indexed for MEDLINE]Related articles

Fuel metabolism in anorexia nervosa and simple obesity.

Franssila-Kallunki A, Rissanen A, Ekstrand A, Eriksson J, Saloranta C, Widén E, Schalin-Jäntti C, Groop L.

Metabolism. 1991 Jul;40(7):689-94.PMID: 1870422 [PubMed - indexed for MEDLINE]Related articles

Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.

Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR, Groop L.

Diabetologia. 1991 Jun;34(6):409-15.PMID: 1884899 [PubMed - indexed for MEDLINE]Related articles

Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources.

Yki-Järvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen MR.

Am J Physiol. 1991 May;260(5 Pt 1):E680-9.PMID: 2035624 [PubMed - indexed for MEDLINE]Related articles

Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

Eriksson J, Saloranta C, Widén E, Ekstrand A, Franssila-Kallunki A, Schalin C, Groop L.

Diabetologia. 1991 Mar;34(3):192-7.PMID: 1884892 [PubMed - indexed for MEDLINE]Related articles

Metabolic characteristics of autoimmune diabetes mellitus in adults.

Groop LC, Eriksson J, Ekstrand A, Franssila-Kallunki A, Saloranta C, Miettinen A.

Diabetologia. 1991 Jan;34(1):46-51.PMID: 2055339 [PubMed - indexed for MEDLINE]Related articles

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.

Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA.

J Clin Endocrinol Metab. 1991 Jan;72(1):96-107.PMID: 1986032 [PubMed - indexed for MEDLINE]Related articles

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L.

N Engl J Med. 1989 Aug 10;321(6):337-43.PMID: 2664520 [PubMed - indexed for MEDLINE]Related articles

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.

Groop L, Widén E, Franssila-Kallunki A, Ekstrand A, Saloranta C, Schalin C, Eriksson J.

Diabetologia. 1989 Aug;32(8):599-605.PMID: 2506091 [PubMed - indexed for MEDLINE]Related articles

Do sulfonylureas influence hepatic insulin clearance?

Groop LC, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.

Diabetes Care. 1988 Sep;11(8):689-90. No abstract available. PMID: 3065007 [PubMed - indexed for MEDLINE]Related articles

Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents.

Stenman S, Groop PH, Saloranta C, Tötterman KJ, Fyhrqvist F, Groop L.

Diabetologia. 1988 Apr;31(4):206-13.PMID: 3133266 [PubMed - indexed for MEDLINE]Related articles

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.

Diabetes Care. 1987 Nov-Dec;10(6):71-8.PMID: 3123184 [PubMed - indexed for MEDLINE]Related articles

The usefulness of micro- and macrochromatographic determinations of glycohemoglobin in diabetic patients with nephropathy.

Saloranta C, Groop L, Ylinen K, Teramo K, Tolppanen EM, Tallgren LG.

Clin Nephrol. 1986 Apr;25(4):186-92.PMID: 3516481 [PubMed - indexed for MEDLINE]Related articles